(Q44138559)

30 November 2017

title

Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy (English)

1 reference

30 November 2017

1 reference

1 reference

M Poppelreuter

1

1 reference

30 November 2017

J Weis

series ordinal

2

1 reference

30 November 2017

H H Bartsch

series ordinal

3

1 reference

30 November 2017

publication date

1 January 2009

1 reference

Journal of Psychosocial Oncology

30 November 2017

published in

1 reference

30 November 2017

volume

27

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

274-296

1 reference

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

EFNS guidelines on cognitive rehabilitation: report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Evidence-based cognitive rehabilitation: recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

What do cancer patients mean when they complain of concentration and memory problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Cognitive-behavioral management of chemotherapy-related cognitive change

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

The effects of oestrogens and anti-oestrogens on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07347330902776044

10.1080/07347330902776044

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference